APP and familial Alzheimer disease: Investigation of wild-type γ-secretase with six familial Alzheimer’s disease (FAD) mutants in PS1 and five FAD mutants in the Aβ peptide segment of the APP revealed that all mutations were associated with decreased γ-secretase activity and a reduced age of disease onset and death [6].